PKN3 and breast carcinoma: Notably, some phosphoproteomic studies have shown that this phosphorylation is enriched in response to insulin, which is also a potent activator for PKN3 (PhosphoSite database, Leenders et al., 2004), and correlates with PKN3 activity in breast carcinoma tumors (Fig. 4D).